Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-26-081417
Filing Date
2026-07-24
Accepted
2026-07-24 16:33:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea0298964-defa14a_osthera.htm DEFA14A 12668
2 GRAPHIC ea029896401_img1.jpg GRAPHIC 874069
  Complete submission text file 0001213900-26-081417.txt   1217697
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-42195 | Film No.: 261201903
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)